Biosimilar IP Landscaping and 351(k) Litigation
Watch recording
The webinar was aimed at varied aspects and challenges of the biosimilar development process. The speakers covered an analysis of the innovator company’s patent portfolio, identifying and advancing the hurdles of biosimilar development, exploration of important patent assets for helping the biosimilar entrant in devising robust pre-litigation [351(K)] strategy, validity assessment, in-licensing and design around opportunities. They demonstrated an intuitive use of our online analytical tool, which presents a multifaceted examination of a given technology and its sub-sections, in this case a biosimilar IP landscaping, without the necessity of spending endless manual efforts. LexisNexis® Intellectual Property Solutions’ advanced analytics technology offers a 360° view to cater to all the R&D and IP needs in overall biosimilar innovation operations.
What you’ll learn:
- Understand the Innovator’s Portfolio and their current R&D progress around the novel molecule
- Know the quick legal status of relevant patent assets before the Biosimilar Launch – Identify in-licensing patent assets
- Prior assessment of litigation risk: validity assessment, advance preparation of infringement arguments
- Assessment of design around opportunities
- Identification of potential patents for pre-suit licensing negotiations
View the Biosimilar IP Landscaping and 351(k) Litigation slides
Provide actionable insights to support strategic decision-making
Effectively communicate the value of your IP with powerful insights and visualizations, enabling you to turn your patent department into a strategic consulting unit.
Taking patent analytics out of the ‘black box’
With LexisNexis® Intellectual Property Solutions, you benefit from a highly transparent scientific approach to patent data analysis. Forget opaque algorithms and analytics ‘black boxes’, we can show you exactly how we reached at our insights. Patent analytics solution, PatentSight®, is built on the foundation of ground-breaking validated research, which is often cited in leading scientific publications.
Brought together in the patent value indicator, the Patent Asset Index™, this objective approach to assessing patent quality and benchmarking patent portfolios has become a de facto standard in measuring portfolio strength.
High-quality data: a prerequisite for reliable patent analysis
LexisNexis Intellectual Property Solutions validates and quality-assures patent data by assigning patents to their accurate commercial owners and verifying their legal validity and remaining lifetime.
Superior datasets allow you to unveil valuable patent insights and see clearly who wields commercial power over the inventions that underpin promising patents.
Patent analyses conducted with PatentSight have proven to be more reliable than analyses based on unprocessed patent data.
Get actionable insights for strategic decision making
Want to become more effective at managing your patent portfolio, identify worldwide relevant patents and technology trends, assess the competitive landscape, and find partners and licensing opportunities?